BIO-key International, Inc. (NASDAQ: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication solutions, today announced the planned launch of a Mumbai office, its ...
Visualforma will lead the nationwide rollout of BIO-key’s IAM and biometric authentication technologies across Portugal’s public-sector ecosystem, currently comprising more than 250 government ...
Responding to continued dominance of the smartphone and tablet markets by Apple Inc.‘s iPhone and iPad, Wall-based biometric identification company Bio-Key International announced plans to acquire the ...
Investing.com -- BIO-Key International, Inc. (NASDAQ:BKYI) stock surged 42.7% in premarket trading Wednesday after announcing a strategic partnership with Portuguese technology integrator Visualforma.
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over forty million users. BIO-key ...
BIO-key (BKYI) International announced a strategic partnership with Guinn Partners, a provider of advanced engineering solutions for robotics, drones, and electric propulsion systems. The companies ...
Q2 2025 Management View CEO Michael W. DePasquale reported a "solid Q2 performance with revenue rising 49% versus last year and 6% on a sequential basis." He noted advancements in expense reduction, ...
For the first time in its history, Microsoft has included biosecurity software in its newest operating system, Windows 10. This update gives Microsoft’s 200 million Windows 10 users the opportunity to ...
The MarketWatch News Department was not involved in the creation of this content. HOLMDEL, N.J. and RIYADH, Saudi Arabia, Nov. 07, 2025 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), ...
BIO-Key announced that the National Bank of Egypt is deploying its PortalGuard platform. The implementation of PortalGuard is being done in partnership with Raya Information Technology. See what to ...
BIO-key (NASDAQ:BKYI) said it had received a continued listing deficiency notice from the Nasdaq because its share price had not met the $1.00 minimum closing bid price requirement for 30 consecutive ...
James Sullivan, VP of Strategy & Compliance and CLO of BIO-Key International, Inc. (NASDAQ: BKYI), was recently interviewed by Benzinga. The company is a trusted provider of Identity and Access ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results